A non-randomized, open-label, roll-over study with adalimumab in adult Japanese subjects with rheumatoid arthritis.
Phase of Trial: Phase II
Latest Information Update: 02 Feb 2010
At a glance
- Drugs Adalimumab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 09 Jan 2009 Planned number of patients changed from 36 to 25 as reported by ClinicalTrials.gov.
- 09 Jan 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.